First Trust, one of the largest issuers of smart beta exchange traded funds, is throwing in the towel on the First Trust Taiwan AlphaDEX Fund. First Trust is reconfiguring, rather than shuttering, the fund.
The First Trust Taiwan AlphaDEX Fund is now the First Trust India NIFTY 50 Equal Weight ETF NFTY. The fund had $1.97 million in assets under management as of April 16, according to issuer data.
What Happened
First Trust has an expansive lineup of ETFs following the AlphaDEX methodology, which focuses on “growth factors including three-, six- and 12-month price appreciation, sales-to-price and one-year sales growth, and, separately, on value factors including book value to price, cash flow to price and return on assets,” according to the issuer.
The First Trust Taiwan AlphaDEX Fund struggled to gain traction with investors, prompting the change to the First Trust India NIFTY 50 Equal Weight ETF.
Why It's Important
Prior to NFTY being launched, there were a dozen dedicated India ETFs trading in the U.S. The two largest members of that group are the iShares MSCI India ETF INDA and the WisdomTree India Earnings ETF EPI, which have $5.38 billion and $1.72 billion in assets under management, respectively.
India is one of the largest developing economies. The country is expected to post economic growth of 7.4 percent in its current fiscal year, up from 6.7 percent in fiscal 2018. Growth in Asia's third-largest economy could accelerate to 7.8 percent in fiscal 2020.
What's Next
NFTY is tracking an equal-weight equivalent of the Nifty 50 Index, a gauge of the largest Indian companies.
The NIFTY50 Equal Weight Index represents an alternative weighting index strategy to its market capitalization weighted parent index, the NIFTY 50. The index includes the same companies as its parent, however, weighted equally,” according to NSE India.
NFTY allocates over two-thirds of its combined weight to the technology and financial services sectors. The ETF's annual fee is 0.80 percent, or $80 on a $10,000 investment.
Related Links:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.